

The HIV Screening Machines market is expanding, driven by rising awareness and initiatives for early detection. In 2023, the market size is estimated at approximately $2.5 billion, with a projected CAGR of 8% over the next five years. Increasing government support and technological advancements are significant growth catalysts.
◍ Roche
◍ Siemens
◍ Danaher
◍ Abbott Laboratories
◍ Bio-Rad Laboratories
◍ AccuBioTech
◍ BioMerieux
◍ Qiagen
◍ Meridian Bioscience
◍ Hologic
◍ Creative Diagnostics
The HIV Screening Machines Market features key players like Roche, Siemens, and Abbott Laboratories, leveraging advanced technology for enhanced testing efficiency. Companies contribute to market growth through innovation, strategic partnerships, and expanding accessibility. Significant revenue figures include Roche (CHF 61.5 billion) and Abbott Laboratories ($43.1 billion), reflecting robust market involvement.
Request Sample Report
Hospitals
Laboratories
Others
Request Sample Report
Rapid Immunoassay Test
Rapid Molecular Diagnostic Test
Request Sample Report
$ X Billion USD